Dipeptidyl Peptidase 4 Inhibitors
Disorders of the Skeletal Muscle
Antiepileptic Drugs: Potassium Channel Activators
Myasthenia Gravis: Overview and Treatment
Glucose Transporters
cAMP-dependent Protein Kinase Pathways
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 6, 2025

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
Published on: June 14, 2024
1Freeman Health System, KCU-GME Consortium, Joplin, MO 64804, USA.
Sodium/glucose co-transporter 2 (SGLT2) inhibitors, used for diabetes and heart failure, may cause drug-induced myopathy. A patient experienced muscle pain and weakness after starting empagliflozin, which resolved upon discontinuation.
Area of Science:
Background: